Status:
COMPLETED
Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Covid19
Sars-CoV2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The management of patients with SARS-CoV2 in respiratory distress can expose to corneal or retinal lesions induced by the stay in intensive care. Examination by ophthalmologists would make it possibl...
Eligibility Criteria
Inclusion
- patient SARS-CoV2 positive (RT-PCR or chest scanner)
- hospitalized in intensive care
Exclusion
- traumatic lesion of the face or any other condition preventing any ophthalmological evaluation
Key Trial Info
Start Date :
April 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2020
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04385810
Start Date
April 27 2020
End Date
July 29 2020
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation Adolphe de Rothschild
Paris, France, 75019